APA (7th ed.) Citation

P, D. M., M, C., L, B., P, C., & C, R. (2024). LOX, but not LOXL2, promotes bone metastasis formation and bone destruction in triple-negative breast cancer. Journal of bone oncology, 44, 100522. https://doi.org/10.1016/j.jbo.2024.100522

Chicago Style (17th ed.) Citation

P, Di Mauro, Croset M, Bouazza L, Clézardin P, and Reynaud C. "LOX, but Not LOXL2, Promotes Bone Metastasis Formation and Bone Destruction in Triple-negative Breast Cancer." Journal of Bone Oncology 44 (2024): 100522. https://doi.org/10.1016/j.jbo.2024.100522.

MLA (9th ed.) Citation

P, Di Mauro, et al. "LOX, but Not LOXL2, Promotes Bone Metastasis Formation and Bone Destruction in Triple-negative Breast Cancer." Journal of Bone Oncology, vol. 44, 2024, p. 100522, https://doi.org/10.1016/j.jbo.2024.100522.